ANTITROMBOTIC ACTIVITY OF A NEW BENZIMIDAZOLE DERIVATIVE WITH A SPATIALLY DIFFICULT PHENOLIC SUBSTITUTE IN ITS STRUCTURE

ANTITROMBOTIC ACTIVITY OF A NEW BENZIMIDAZOLE DERIVATIVE WITH A SPATIALLY DIFFICULT PHENOLIC SUBSTITUTE IN ITS STRUCTURE

The aim of the study was to investigate antithrombogenic properties of compound RU-1144 with previously identified pronounced antiplatelet and antioxidant activities. The thrombosis induced by Ferric chloride (FeCl3) was carried out in rats’ carotid artery, in comparison with the known antiaggregant...

Full description

Bibliographic Details
Main Authors:	Alexander A. Spasov, Aida F. Kucheryavenko, Ksenia A. Gaidukova, Maxim V. Chernikov, Olga N. Zhukovskaya
Format:	Article
Language:	Russian
Published:	Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University 2020-10-01
Series:	Farmaciâ i Farmakologiâ (Pâtigorsk)
Subjects:	antithrombotic activity thrombosis benzimidazole asa clopidogrel ethylmethylhydroxypyridine succinate the görög thrombosis test bleeding time
Online Access:	https://www.pharmpharm.ru/jour/article/view/685

Similar Items

EVIDENCE BASE OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE USE IN PATIENTS WITH STROKE AND ITS CONSEQUENCES
by: A. D. Ehrlikh, et al.
Published: (2015-09-01)

Thrombosis prevention in percutaneous coronary interventions
by: V. P. Lupanov, et al.
Published: (2009-08-01)

Reaction of the hemostatic system in response to hypercapnic hypoxia of maximum intensity depending on different types of preconditioning
by: S V Moskalenko, et al.
Published: (2019-07-01)

In silico and antithrombotic studies of 1,3,4-oxadiazoles derived from benzimidazole
by: B. Vishwanathan, et al.
Published: (2015-12-01)

Bleeding risk in endoscopic retrograde cholangiopancreatography: impact of the use of antithrombotic drugs
by: Fernando Alberca-de-las-Parras, et al.

Chemoreactome analysis of ethylmethylhydroxypyridine succinate
by: O. A. Gromova, et al.
Published: (2016-11-01)

EFFECT OF THE ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE ON THE OXIDATIVE MODIFICATION OF SERUM PROTEINS IN PATIENTS WITH ISCHEMIC STROKE
by: T. N. Khaybullin, et al.
Published: (2015-12-01)

Investigation of Antithrombotic Drug Effects on Preventing Thrombosis Emerging in Gluteus Maximus Flaps before Anastomosis
by: Ertem K, et al.
Published: (2012-06-01)

PROTECTION OF BRAIN MITOCHONDRIA AGAINST MICRO STROKE-INDUCED INJURY: A STUDY OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN EXPERIMENTAL MODEL USING TWO PHOTON LASER FLUORESCENT MICROSCOPY
by: R. A. Afzalov, et al.
Published: (2016-08-01)

COMPLEX ASSESSMENT OF EFFECTIVENESS OF THE DRUG GROUP ANTIHYPOXANTSIN PATIENTS WITH ANGINA AND HIGH LEVEL ANXIETY
by: G. I. Nechaeva, et al.
Published: (2017-11-01)

The triple synergy of ethylmethylhydroxypyridine succinate, magnesium, and vitamin B6: Molecular mechanisms
by: O. A. Gromova, et al.
Published: (2017-03-01)

Dual antiplatelet therapy challenges in emergent noncardiac surgeries
by: Rahil Singh, et al.
Published: (2021-01-01)

Antithrombotic effect of repeated doses of the ethanolic extract of local olive (Olea europaea L.) leaves in rabbits
by: Abdallah M. Dub, et al.
Published: (2013-05-01)

THIOL ISOMERASES – A POSSIBLE TARGET FOR THROMBOSIS CONTROL
by: I. V. Gribkova, et al.
Published: (2017-12-01)

Obesity, leptin, and thrombosis: Focus on clopidogrel resistance
by: Bilgehan Karadağ
Published: (2016-10-01)

IATROGENIC EVENTS OF ORAL ANTITHROMBOTIC THERAPY. BETWEEN SCYLLA AND CHARYBDIS
by: L. I. Dvoretsky, et al.
Published: (2016-12-01)

In vivo antithrombotic properties of a heparin from the oocyte test cells of the sea squirt Styela plicata(Chordata-Tunicata)
by: L. Cardilo-Reis, et al.
Published: (2006-11-01)

NEOnatal Central-venous Line Observational study on Thrombosis (NEOCLOT): evaluation of a national guideline on management of neonatal catheter-related thrombosis
by: Jeanine J. Sol, et al.
Published: (2018-02-01)

Effect of mexidol on the efficiency of intravenous thrombolytic therapy for ischemic stroke during the therapeutic window
by: K. S. Knni, et al.
Published: (2018-11-01)

Chronic cerebral ischemia and headache in patients in primary care physician's practice
by: V. N. Shishkova, et al.
Published: (2021-02-01)

Effectiveness of Two-Year versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis after Drug-Eluting Stent Implantation
by: Hamid Reza Poorhosseini, et al.
Published: (2012-04-01)

Effectiveness of Two-Year Versus One-Year Use of Dual Antiplatelet Therapy in Reducing the Risk of Very Late Stent Thrombosis After Drug-Eluting Stent Implantation
by: Ali Reza Amirzadegan, et al.
Published: (2012-06-01)

Omeprazol y clopidogrel asociado a trombosis de stent
by: Ricardo Amador García Hernández, et al.

Pharmacogenomic Testing and Antithrombotic Therapy: Ready for Prime Time?
by: David R. Holmes, Jr.
Published: (2013-01-01)

Antithrombotic Treatment in Neonatal Cerebral Sinovenous Thrombosis
by: J Gordon Millichap
Published: (2010-05-01)

P2Y12 Receptor Function and Response to Cangrelor in Neonates With Cyanotic Congenital Heart Disease
by: Elisabeth A. Kaza, MD, et al.
Published: (2017-08-01)

Thromboembolic Complications in Covid-19: From Clinical Scenario to Laboratory Evidence
by: Alberto Palazzuoli, et al.
Published: (2021-04-01)

COVID-19: hemostatic parameters and specifics of antithrombotic treatment
by: I. S. Yavelov, et al.
Published: (2020-07-01)

CLINICAL EXPERIENCE WITH METABOLIC THERAPY FOR BRAIN ISCHEMIA
by: M. Kh. Shurdumova, et al.
Published: (2014-07-01)

Cerebral Circulation and Metabolism of Patients with Cerebral Injury
by: Ekaterina A. Abramova, et al.
Published: (2018-03-01)

Chemotranscriptome analysis of the ethylmethylhydroxypyridine succinate molecule in the context of postgenomic pharmacology
by: O. A. Gromova, et al.
Published: (2020-10-01)

CLINICAL EXPERIENCE WITH METABOLIC THERAPY FOR BRAIN ISCHEMIA
by: M. Kh. Shurdumova, et al.
Published: (2014-07-01)

Clinical Valve Thrombosis and Subclinical Leaflet Thrombosis Following Transcatheter Aortic Valve Replacement: Is There a Need for a Patient-Tailored Antithrombotic Therapy?
by: Liesbeth Rosseel, et al.
Published: (2019-04-01)

THE EFFECTIVENESS OF CLOPIDOGREL AS AN ANTITHROMBOTIC COMPARED TO TICLOPIDINE AND ASPIRIN (META-ANALYSIS)
by: Titien Siwi Hartayu, et al.
Published: (2017-05-01)

The influence of prolonged antithrombotic therapy on the development of post-thrombotic syndrome in patients with proximal deep vein thrombosis of the lower limbs
by: A. S. Petrikov, et al.
Published: (2018-12-01)

Case Series about the Changed Antiplatelet Protocol for Carotid Endarterectomy in a Teaching Hospital: More Patients with Complications?
by: Martijn S. Marsman, et al.
Published: (2018-10-01)

A multimodal approach in the treatment of chronic cerebral ischemia: what should a doctor know?
by: N. V. Pizova
Published: (2020-05-01)

Possibilities of chronic brain ischemia manifestations correction in outpatient practice
by: O. A. Shavlovskaya, et al.
Published: (2021-01-01)

Acute cerebral circulatory disorders and coronavirus disease
by: N. V. Pizova, et al.
Published: (2020-07-01)

Acute cerebral venous sinus thrombosis: two different presentations
by: Buket Kilicaslan, et al.
Published: (2014-08-01)